Dennis Ding
Stock Analyst at Jefferies
(0.10)
# 4,310
Out of 4,944 analysts
13
Total ratings
11.11%
Success rate
-16.07%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Dennis Ding
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INDV Indivior | Assumes: Buy | $20 | $22.84 | -12.43% | 1 | Jul 22, 2025 | |
| MLYS Mineralys Therapeutics | Initiates: Hold | $15 | $13.51 | +11.03% | 1 | Jun 11, 2025 | |
| CRNX Crinetics Pharmaceuticals | Upgrades: Buy | $55 | $28.48 | +93.12% | 1 | Jan 22, 2025 | |
| IKT Inhibikase Therapeutics | Initiates: Buy | $8 | $1.75 | +357.14% | 1 | Nov 8, 2024 | |
| ASMB Assembly Biosciences | Upgrades: Buy | $2 → $35 | $23.91 | +46.38% | 1 | Sep 20, 2024 | |
| FOLD Amicus Therapeutics | Initiates: Buy | $18 | $6.98 | +157.88% | 1 | Sep 6, 2024 | |
| ABUS Arbutus Biopharma | Maintains: Buy | $5 → $7 | $3.40 | +106.19% | 2 | Sep 5, 2024 | |
| RXRX Recursion Pharmaceuticals | Maintains: Hold | $8 → $6 | $5.41 | +10.91% | 1 | Sep 3, 2024 | |
| LYRA Lyra Therapeutics | Downgrades: Hold | $500 → $25 | $6.75 | +270.37% | 1 | May 7, 2024 | |
| CORT Corcept Therapeutics | Downgrades: Hold | $35 → $22 | $73.59 | -70.10% | 1 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $25.00 | -4.00% | 1 | Dec 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $11.58 | -13.61% | 1 | Oct 26, 2021 |
Indivior
Jul 22, 2025
Assumes: Buy
Price Target: $20
Current: $22.84
Upside: -12.43%
Mineralys Therapeutics
Jun 11, 2025
Initiates: Hold
Price Target: $15
Current: $13.51
Upside: +11.03%
Crinetics Pharmaceuticals
Jan 22, 2025
Upgrades: Buy
Price Target: $55
Current: $28.48
Upside: +93.12%
Inhibikase Therapeutics
Nov 8, 2024
Initiates: Buy
Price Target: $8
Current: $1.75
Upside: +357.14%
Assembly Biosciences
Sep 20, 2024
Upgrades: Buy
Price Target: $2 → $35
Current: $23.91
Upside: +46.38%
Amicus Therapeutics
Sep 6, 2024
Initiates: Buy
Price Target: $18
Current: $6.98
Upside: +157.88%
Arbutus Biopharma
Sep 5, 2024
Maintains: Buy
Price Target: $5 → $7
Current: $3.40
Upside: +106.19%
Recursion Pharmaceuticals
Sep 3, 2024
Maintains: Hold
Price Target: $8 → $6
Current: $5.41
Upside: +10.91%
Lyra Therapeutics
May 7, 2024
Downgrades: Hold
Price Target: $500 → $25
Current: $6.75
Upside: +270.37%
Corcept Therapeutics
Feb 15, 2023
Downgrades: Hold
Price Target: $35 → $22
Current: $73.59
Upside: -70.10%
Dec 19, 2022
Initiates: Buy
Price Target: $24
Current: $25.00
Upside: -4.00%
Oct 26, 2021
Initiates: Buy
Price Target: $10
Current: $11.58
Upside: -13.61%